HomeCompareIPXL vs JEPQ

IPXL vs JEPQ: Dividend Comparison 2026

IPXL yields 10.93% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPQ wins by $3.6K in total portfolio value
10 years
IPXL
IPXL
● Live price
10.93%
Share price
$18.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.2K
Annual income
$2,167.08
Full IPXL calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — IPXL vs JEPQ

📍 JEPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIPXLJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IPXL + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IPXL pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPXL
Annual income on $10K today (after 15% tax)
$928.96/yr
After 10yr DRIP, annual income (after tax)
$1,842.02/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, IPXL beats the other by $12.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPXL + JEPQ for your $10,000?

IPXL: 50%JEPQ: 50%
100% JEPQ50/50100% IPXL
Portfolio after 10yr
$43.0K
Annual income
$2,159.83/yr
Blended yield
5.03%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPXL buys
0
JEPQ buys
0
No recent congressional trades found for IPXL or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIPXLJEPQ
Forward yield10.93%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$41.2K$44.8K
Annual income after 10y$2,167.08$2,152.59
Total dividends collected$16.2K$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: IPXL vs JEPQ ($10,000, DRIP)

YearIPXL PortfolioIPXL Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$11,793$1,092.90$11,930$1,110.39$137.00JEPQ
2$13,823$1,204.52$14,133$1,224.34$310.00JEPQ
3$16,110$1,319.51$16,632$1,340.46$522.00JEPQ
4$18,675$1,437.22$19,454$1,457.97$779.00JEPQ
5$21,539$1,557.05$22,626$1,576.08$1.1KJEPQ
6$24,725$1,678.38$26,175$1,694.09$1.4KJEPQ
7$28,257$1,800.61$30,133$1,811.32$1.9KJEPQ
8$32,158$1,923.16$34,531$1,927.17$2.4KJEPQ
9$36,454$2,045.49$39,403$2,041.08$2.9KJEPQ
10$41,173$2,167.08$44,787$2,152.59$3.6KJEPQ

IPXL vs JEPQ: Complete Analysis 2026

IPXLStock

A technology-based specialty pharmaceutical company focused on the development, manufacturing, and commercialization of controlled drug delivery systems, generic formulations, and branded pharmaceutical products across two main segments: Impax Generics and Impax Specialty Pharma

Full IPXL Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this IPXL vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPXL vs SCHDIPXL vs JEPIIPXL vs OIPXL vs KOIPXL vs MAINIPXL vs XYLDIPXL vs QYLDIPXL vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.